Industry Experts

Bryan Hart, Ph.D. is a Business Development Manager at Minaris Advanced Therapies, where he manages client partnerships and builds new collaborations in analytical development and testing services across biologics and cell & gene therapies. With more than a decade of experience leading analytical strategy and assay development at Novoglia, Shoreline Biosciences, Poseida Therapeutics, Seqirus, and Novartis, Bryan has guided programs advancing cell therapy, immunotherapy, and vaccine platforms from early development through GMP readiness. He holds a Ph.D. in Microbiology (Immunology concentration) from the University of Illinois at Urbana-Champaign and completed postdoctoral research at Duke University focused on vaccines and infectious disease immunology.